Urol. praxi, 2012; 13(5): 204-207

Management of the urotelial carcinomas in the upper urinary tract

MUDr.Oto Kőhler, CSc., MUDr.Kamil Belej, Ph.D., FEBU
Urologické oddělení, Ústřední vojenská nemocnice &ndash, Vojenská fakultní nemocnice, Praha

Urothelial carcinomas in the upper urinary tract (UUT-UCC) account 5–10 % of all UCCs. Development of new endoscopes, new diagnostic

and therapeutic tools allowed us to offer more kidney sparing procedures to the pacients with localised UUT-UCC with low malignity potential.

With respect to the fact, that more than 60 % of UUT-UCC are invasive carcinomas radical nephrouretrerectomy is still a gold standard.

Keywords: urothelial carcinoma, upper urinary tract, endourology

Published: October 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kőhler O, Belej K. Management of the urotelial carcinomas in the upper urinary tract. Urol. praxi. 2012;13(5):204-207.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Národní onkologický registr ČR, dostupný z www.svod.cz.
    2. Macek P, Soukup V, a kol. Zhodnocení charakteru a vývoje onemocnění u nemocných s uroteliálními nádory horních močových cest. Endoskopie 2011; 20(3 a 4): 89-92.
    3. Babaian RJ, Johnson DE. Primary carcinoma of the ureter. J Urol, 1980; 123: 357-359. Go to original source... Go to PubMed...
    4. Zincke H, Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin N Am, 1984; 11: 717-724. Go to original source...
    5. Roupręt M, Yates DR, Comperat E, et al. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Eur Urol, 2008; 54(6): 1226-1236. Go to original source... Go to PubMed...
    6. Wang LJ, Wong YC, Chuang CK, et al. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol, 2009; Feb; 181(2): 524-531; discussion 531. Go to original source... Go to PubMed...
    7. Keely FX, Bibbo M Jr, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol, 1997; 157: 1560-1565. Go to original source... Go to PubMed...
    8. Hora M, Klečka J, a kol. Současné možnosti provedení nefroureterektomie. Urologické listy, 2007; 5: 83-89.
    9. Kőhler O. Endoskopická léčba uroteliálních karcinomů horních močových cest. Urologické listy, 2004; 3: 53-59.
    10. Kőhler O. Endoskopická léčba uroteliálních karcinomů horních močových cest. in: Dvořáček J. Babjuk M. Onkourologie. Galén, s.r.o., 2005, ISBN: 80-7262-349-4; 85-90.
    11. Elliott DS, Blute ML, Patterson DE, et al. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology, 1996; 47: 819-825. Go to original source... Go to PubMed...
    12. Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: Analysis of a series of 59 tumors. J Urol, 1996; 156: 377-385. Go to original source... Go to PubMed...
    13. Tawfiek ER, Bagley D. Upper-tract transitional cell carcinoma. Urology, 1997; 50: 321-329. Go to original source... Go to PubMed...
    14. Lim DJ, Shattuck MO, et al. Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol, 1993; 149: 109-111. Go to original source... Go to PubMed...
    15. Kőhler O, Kawaciuk I, Černý J, Jerie J. Perkutánní nefrolitotomie. Rozhl chir, 1994; 73: 269-272. Go to PubMed...
    16. Kőhler O, Fencl P. Strategie a taktika v léčbě pooperačního krvácení po retrográdní endopyelotomii. Česká Urol, 2000; 2: 9-14.
    17. Hopper KD, Yakes WF. The posterior intercostal approach for percutaneous renal procedures: risk of puncturing the lung, spleen, and liver as determined by CT. AJR, 1990; 154: 115-117. Go to original source... Go to PubMed...
    18. Jabbour ME, Smith AD. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am, 2000; 27: 739-750. Go to original source... Go to PubMed...
    19. Studer UE, Casanova G, Kraft R, et al. Percutaneous bacillus Camette-Guérin perfusion of the upper urinary tract for carcinoma in situ. J Urol, 1989; 142: 975-977. Go to original source... Go to PubMed...
    20. Woodhouse CRJ, Kellet MJ, Bloom HJG. Percutaneous renal surgery and local radiotherapy in the management of renal pelvic transitional cell carcinoma. Br J Urol, 1986; 58: 245-249. Go to original source... Go to PubMed...
    21. ##
    22. Czito B, Zietman A, Kaufman D, et al. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 2004; 172: 1271-1275. Go to original source... Go to PubMed...
    23. Maulard-Durdux C, Dufour B, Hennequin C, et al. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol 1996; 155: 115-117. Go to original source... Go to PubMed...
    24. Cozad SC, Smalley SR, Austenfeld M, et al. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 1995; 46: 796-800. Go to original source... Go to PubMed...
    25. Chen B, Zeng ZC, Wang GM, et al. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer 2011; 11: 297. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.